Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Conditions
- Adult Primary Hepatocellular Carcinoma
- Localized Resectable Adult Primary Liver Cancer
- Localized Unresectable Adult Primary Liver Cancer
- Recurrent Adult Primary Liver Cancer
Interventions
- DRUG: sorafenib tosylate
- OTHER: placebo
- OTHER: laboratory biomarker analysis
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators